FINW compared with DERM: revenue, margins and what each company keeps, and the suppliers and customers both name

FINWFinwise Bancorp

Mkt capRevenueRevenue

DERMJourney Medical Corp

Mkt capRevenueRevenue

Compare

FINWFinwise Bancorp

DERMJourney Medical Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

FINW

Reportimpliedrealized× implied

Oct 29 '26—▲+23.20%—

Q2 FY26—▼−2.77%—

Q1 FY26—▼−3.79%—

Jan 30 '26—▼−5.09%—

DERM

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±84.3%▲+3.42%×0.04

May 14 '26±25.1%▲+22.35%×0.89

= impliedFINW realized, solidDERM realized, hatchedOne scale, both sides: full bar = 88%× = |realized| ÷ impliedSource: market data

Q1 FY26

±87.6%

▼−30.01%

×0.34

Q3 FY25±56.7%▼−15.31%×0.27

FINWFinwise Bancorp

10.83▼−20.78%· post 13.78

Mkt cap$189.9MRevenue$54MQ2 FY26Revenue$131MFY25

DERMJourney Medical Corp

4.42▲+2.88%· post 4.49

ClosedNov 6 '26

Mkt cap$126.2MRevenue$19MQ2 FY26Revenue$62MFY25

Compare

ClosedNov 6 '26

FINWFinwise Bancorp

DERMJourney Medical Corp

10.83▼−20.78%post 13.78

Price

4.42▲+2.88%post 4.49

$189.9M

Mkt cap

$126.2M

Q2 FY26$54M

Revenue

$19MQ2 FY26

FY25$131M

Revenue

$62MFY25

FINW10.83▼−20.78%vsDERM4.42▲+2.88%ClosedNov 6 '26